Clinical Trial Update: Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing utidelone to docetaxel in locally advanced or metastatic non-small cell lung cancer is underway, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Utidelone (utidelone)

Snippet

Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. | Conditions: Locally Advanced or Metastatic Non-Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN